Section B: Value proposition - non-assessed section

This is section B of the Digital Technology Assessment Criteria (DTAC).

In this section, developers are asked to set out the context of the clinical, economic or behavioural benefits of your product to support the review by our specialists. This criteria will not be assessed but will provide the context of the product that is to be assessed.

B1 - What are the intended or proven benefits for users accessing or using your product?

What evidence can you provide to support the product or service value proposition? For example: improvements in patients outcomes or experience, generation of new knowledge of capabilities, generation of a firmer evidence base or reduction in uncertainty, efficiency improvements.

B2 - What evidence can you provide to support the product or service value proposition?

Response option: Free text

Supporting guidance: For example: 

  • Expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles" 
  • Case series (and poor-quality cohort and case-control studies) 
  • Individual case-control study 
  • Systematic review (with homogeneity) of case-control studies 
  • "Outcomes" Research; ecological studies 
  • Individual cohort study or low quality randomized controlled trials (e.g. <80% follow-up) 
  • Systematic reviews (with homogeneity) of cohort studies 
  • All or none randomized controlled trials 
  • Individual randomized controlled trials (with narrow confidence interval) 
  • Systematic reviews (with homogeneity) of randomized controlled trials.


B3 - Upload relevant documentation or provide relevant URLs

Response option: Text | File | Text and File

Supporting guidance: Upload all relevant information such as:

  • Published articles

  • Expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles" 

  • Case series (and poor-quality cohort and case-control studies) 

  • Individual case-control study 

  • Systematic review (with homogeneity) of case-control studies 

  • "Outcomes" Research; ecological studies

  • Individual cohort study or low quality randomized controlled trials (e.g. <80% follow-up) 

  • Systematic reviews (with homogeneity) of cohort studies 

  • All or none randomized controlled trials 

  • Individual randomized controlled trials (with narrow confidence interval) 

  • Systematic reviews (with homogeneity) of randomized controlled trials.


Next section

Continue on to section C: Assessment criteria.